NCT04202029View on ClinicalTrials.gov

Additional Benefit of Thoracic Impedance Monitoring (TIM) for Propofol-sedation Monitoring During PEG Placement

NACompletedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

August 24, 2021

Study Completion Date

August 24, 2021

Conditions
Percutaneous Endoscopic Gastrostomy (PEG)
Interventions
DEVICE

thoracic impedance monitoring

Thoracic impedance measurement identifies the respiratory frequence using the changes of impedance during inspiration and expiration via an ECG.

DEVICE

pulseoxymetry

Pulseoxymetry is meassuring the heart rate and the oxygen saturation in the arterial blood

DEVICE

non-invasive blood preassure monitoring

Non-invasive blood preassure is a method using a blood preassure cuff to identify the blood preassure.

Trial Locations (1)

60590

Klinikum der J. W. Goethe-Universität, Frankfurt am Main

All Listed Sponsors
lead

Georg Dultz

OTHER

NCT04202029 - Additional Benefit of Thoracic Impedance Monitoring (TIM) for Propofol-sedation Monitoring During PEG Placement | Biotech Hunter | Biotech Hunter